Skip to main content
Category

News Archive

GlaxoSmithKline-gsk-logo

FDA Approves GSK’s Shingles Vaccine with Agenus’ QS-21 Stimulon® Adjuvant | Markets Insider

By News Archive

GlaxoSmithKline-gsk-logo

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, announced today that the US Food and Drug Administration (FDA) granted marketing authorization to GlaxoSmithKline’s (GSK) herpes zoster vaccine, SHINGRIX, containing Agenus’ proprietary immune adjuvant QS-21 Stimulon®. SHINGRIX is indicated for prevention of herpes zoster (also known as shingles) in adults aged 50 years and older. The addition of QS-21 Stimulon helps improve the vaccine’s effectiveness by boosting immune response in older adults who often experience age-related decline in immunity.   

Read More
astrazeneca-medimmune-logo

It’s official: AstraZeneca and MedImmune ranked a top place for scientists to work by Science

By News Archive

astrazeneca-medimmune-logo

AstraZeneca and MedImmune, our global biologics research and development arm, have been voted one of the top science employers worldwide, in the prestigious Science 2017 Top Employers Survey1.

Our key strengths, as highlighted by survey participants, focused on our aspirational work culture, our dynamic and intellectually challenging environment, and our commitment to collaboration, which our scientists enjoy at research centres across the globe. 

Read More
black-and-white-md-tech-logo

Black & White Affair

By News Archive

black-and-white-md-tech-logo

Thursday, December 07, 2017 5:30 PM – 7:30 PM EST

Horseshoe Casino Baltimore 1525 Russell Street Baltimore, MD 21230

We’re excited to announce MTC’s first annual Black & White Affair. Our exclusive holiday party will feature gourmet appetizers, music, unique silent auction items and cocktails as you help fund internships through the inMD platform.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.